Metabolite perturbations in type 1 diabetes associated with metabolic dysfunction-associated steatotic liver disease

BackgroundMetabolic dysfunction-associated steatotic liver disease (MASLD), formerly called non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome. Although MASLD has been widely studied in persons with Type 2 diabetes (T2D), far less in known about the path...

詳細記述

書誌詳細

出版年:	Frontiers in Endocrinology
主要な著者:	Adeyinka Taiwo, Ronald A. Merrill, Linder Wendt, Daniel Pape, Himani Thakkar, J. Alan Maschek, James Cox, Scott A. Summers, Bhagirath Chaurasia, Nikitha Pothireddy, Bianca B. Carlson, Antonio Sanchez, Patrick Ten Eyck, Diana Jalal, Ayotunde Dokun, Eric B. Taylor, William I. Sivitz
フォーマット:	論文
言語:	英語
出版事項:	Frontiers Media S.A. 2025-06-01
主題:	NAFLD MASLD NASH MASH Type 1 diabetes Type 2 diabetes
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1500242/full